The Centre unveiled its BioE3 (Biotechnology for Economy, Environment and Employment) policy last week. On the face of it, the policy appears to be a routine attempt to create incentives and ...
Recursion reported mixed data Tuesday from its first Phase 2 study, in a disappointing start to an expected frenzy of clinical results.
WHEN the Covid-19 pandemic broke out, countries scrambled for a way to quickly detect the disease. This brought public attention to the field of genomics – a branch of molecular biology concerned with ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in ...
These companies are nearly in the sweet spot of risk versus reward in biotech. Many investors rightfully identify biotech stocks as being riskier than average, and those stocks certainly have a ...
This has apparently been done to "maximize the performance" of the S25 series. The Exynos 2500 will instead be used in the Galaxy Z Fold7 and Galaxy Z Flip7 that will be released in the second ...
Zydus Lifesciences Ltd announced today that its wholly-owned subsidiary, Zydus Animal Health and Investments Ltd, has completed the acquisition of a 50 per cent equity stake in Sterling Biotech ...
Dhaval Patel, M.D., Ph.D. (Sana Biotechnology) Dhaval Patel, M.D., Ph.D., is joining cell engineering biotech Sana Biotechnology as its first chief scientific officer following his tenure in the s ...
Super Micro Computer SMCI has outperformed the market over the past 5 years by 75.86% on an annualized basis producing an average annual return of 89.97%. Currently, Super Micro Computer has a ...
BioMarin Pharmaceutical, a San Rafael biotech company known for treating extremely rare diseases, said Wednesday it’s laying off 225 workers, most of whom live and work in California.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback